Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Cancer|June 1, 1989
Long-term survivors after resection for primary liver cancer. Clinical analysis of 19 patients surviving more than ten yearsX D Zhou, Z Y Tang, Y Q Yu, et al.Parasitology|August 19, 2007
Type I and type II fatty acid biosynthesis in Eimeria tenella: enoyl reductase activity and structureJ Z Lu, S P Muench, M Allary, et al.Journal of Gastroenterology|October 1, 1995
Characteristics and prognosis of primary liver cancer in young patients in ChinaX D Zhou, Z Y Tang, Y Q Yu, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1993
Radioimmunotherapy for unresectable hepatocellular carcinoma using 131I-Hepama-1 mAb: preliminary resultsZ C Zeng, Z Y Tang, H Xie, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1991
Preliminary result of mixed bacterial vaccine as adjuvant treatment of hepatocellular carcinomaZ Y Tang, H Y Zhou, G Zhao, et al.Digestive Surgery|December 9, 1998
Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinomaJ Fan, Z Y Tang, Y Q Yu, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 1, 1997
Three decades' experience in surgery of hepatocellular carcinomaZ Y Tang, Y Q Yu, X D Zhou, et al.Journal of Surgical Oncology|May 1, 1991
Cytoreduction and sequential resection: a hope for unresectable primary liver cancerZ Y Tang, Y Q Yu, X D Zhou, et al.Cancer|January 15, 1990
Radioimmunotherapy in the multimodality treatment of hepatocellular carcinoma with reference to second-look resectionZ Y Tang, K D Liu, Y M Bao, et al.World Journal of Surgery|January 1, 1995
Treatment of unresectable primary liver cancer: with reference to cytoreduction and sequential resectionZ Y Tang, Y Q Yu, X D Zhou, et al.Pageof 5